(cis)12-(4-hydroxy-3,5-dimethoxyphenyl)-(5aS,12S,14aS)-2,3,5a,6,11,12,14,14a-octahydro-1H,5H-pyrrolo[1',2':4,5]pyrazino[1,2-b]b-carboline-5,14-dione

ID: ALA40266

Chembl Id: CHEMBL40266

PubChem CID: 10599530

Max Phase: Preclinical

Molecular Formula: C25H25N3O5

Molecular Weight: 447.49

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc([C@H]2c3[nH]c4ccccc4c3C[C@H]3C(=O)N4CCC[C@H]4C(=O)N23)cc(OC)c1O

Standard InChI:  InChI=1S/C25H25N3O5/c1-32-19-10-13(11-20(33-2)23(19)29)22-21-15(14-6-3-4-7-16(14)26-21)12-18-24(30)27-9-5-8-17(27)25(31)28(18)22/h3-4,6-7,10-11,17-18,22,26,29H,5,8-9,12H2,1-2H3/t17-,18-,22-/m0/s1

Standard InChI Key:  KBWONIAAZHWKLL-SPEDKVCISA-N

Associated Targets(Human)

Panel leukemia (Carcinoma cell lines) (209 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Colon cell (36 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNS cell (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Melanoma cell (242 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ovarian carcinoma cell (138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Renal cell (31 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Prostate cell (31 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Breast carcinoma cell (217 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

NSO (113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
3Y1 cell line (119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 447.49Molecular Weight (Monoisotopic): 447.1794AlogP: 2.74#Rotatable Bonds: 3
Polar Surface Area: 95.10Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.31CX Basic pKa: CX LogP: 2.01CX LogD: 2.01
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.64Np Likeness Score: 0.34

References

1. Wang H, Usui T, Osada H, Ganesan A..  (2000)  Synthesis and evaluation of tryprostatin B and demethoxyfumitremorgin C analogues.,  43  (8): [PMID:10780915] [10.1021/jm9905662]

Source